Telix takes on ‘next-gen’ cancer drug candidates through $372m asset buy
Telix Pharmaceuticals Ltd (ASX:TLX) is adding to its portfolio of early-stage drug…
Telix Pharmaceuticals Limited (ASX:TLX)
About Telix Pharmaceuticals Limited
Key Information
TLX In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 17/01/2025 | Price Sensitive PS Illuccix Receives European Approval | 149.34KB | 48K |
| 13/01/2025 | Price Sensitive PS Telix JP Morgan Healthcare Conference 2025 Presentation | 4.03MB | 4.3K |
| 13/01/2025 | Price Sensitive PS Telix Exceeds FY24 Guidance with US$142M Q4 Revenue | 166.97KB | 24K |
| 13/01/2025 | Proposed issue of securities - TLX | 19.54KB | 403 |
| 13/01/2025 | Price Sensitive PS Presentation to Accompany Biologics Platform Acquisition | 883.41KB | 538 |
| 13/01/2025 | Price Sensitive PS TLX to Acquire Next-Gen Therapeutics and Biologics Platform | 216.73KB | 5.6K |
| 09/01/2025 | Notification of cessation of securities - TLX | 13.52KB | 582 |
| 30/12/2024 | Managing Director and Group CEO Remuneration Update | 139.19KB | 4.2K |